AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Jezik: | English |
Izdano: |
Elsevier
2023-10-01
|
Serija: | IBRO Neuroscience Reports |
Online dostop: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |